Clinical Trial Update: Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining how escitalopram affects sleep architecture in patients with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Sheba Medical Center | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN